SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)

NCT00093951 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
280
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Saegis Pharmaceuticals